Methionine-Induced Homocysteinemia Impairs Endothelial Function in Hypertensives: The Role of Asymmetrical Dimethylarginine and Antioxidant Vitamins
Author(s) -
D. Tousoulis,
George Bouras,
Charalambos Antoniades,
K. Marinou,
Νικόλαος Παπαγεωργίου,
Antigoni Miliou,
Georgios Hatzis,
Elli Stefanadi,
Costas Tsioufis,
Christodoulos Stefanadis
Publication year - 2011
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2011.65
Subject(s) - asymmetric dimethylarginine , endothelial dysfunction , homocysteine , medicine , endocrinology , methionine , placebo , endothelium , nitric oxide , hyperhomocysteinemia , arginine , biochemistry , chemistry , amino acid , alternative medicine , pathology
Nitric oxide synthase (NOS) inhibitor asymmetrical dimethylarginine (ADMA) is synthesized by the methylation of arginine as part of the methionine/homocysteine cycle. However, the mechanisms regulating ADMA synthesis in hypertension are unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom